HS
ARNA

Haafor (Singapore)’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Haafor (Singapore)’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$216K Buy
+2,816
New +$211K 0.4% 123

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Haafor (Singapore)'s ARNA Position: Q4 2020 in Review

Haafor (Singapore) opened a new position in Arena Pharmaceuticals Inc (ARNA) in Q4 2020: 2,816 shares worth $216K. The stake represents 0.4% of the portfolio and ranks #123 among its holdings.

254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Haafor (Singapore) held 2,816 shares of Arena Pharmaceuticals Inc worth $216K as of Q4 2020.
  • Arena Pharmaceuticals Inc was a new Haafor (Singapore) position in Q4 2020.
  • Arena Pharmaceuticals Inc made up 0.4% of Haafor (Singapore)'s portfolio in Q4 2020, its #123 holding.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Haafor (Singapore)'s 13F filing for Q4 2020, filed 5 Feb 2021.